The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients With Type 2 Diabetes Mellitus. APMPLMI 2022, 3 (1), 1-10. https://doi.org/10.52914/apmp.v3i1.42.